Mirum Pharmaceuticals (MIRM) Current Leases (2019 - 2024)

Mirum Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $1.7 million for Q4 2024.

• In Q4 2024, Current Leases rose 54.8% year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $1.7 million (up 54.8% YoY), while the FY2024 annual figure was $1.7 million, up 54.8% from the prior year.
• Current Leases was $1.7 million for Q4 2024 at Mirum Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.7 million in Q4 2024 to a low of $358000.0 in Q1 2024.
• Historically, Current Leases has averaged $850800.0 across 5 years, with a median of $741500.0 in 2022.
• The sharpest annual moves came in 2020 and 2024: Current Leases soared 139.82% in 2020, then tumbled 60.83% in 2024.
• A 5-year view of Current Leases shows it stood at $636000.0 in 2020, then increased by 11.79% to $711000.0 in 2021, then surged by 30.94% to $931000.0 in 2022, then rose by 18.58% to $1.1 million in 2023, then soared by 54.8% to $1.7 million in 2024.
• The last three Current Leases figures came in at $1.7 million (Q4 2024), $1.5 million (Q3 2024), and $1.1 million (Q2 2024), per Business Quant data.